Health
FDA approves Lipfendra, the first oral PCSK9 pill for high cholesterol
The FDA has approved Lipfendra, the first oral PCSK9 inhibitor for high cholesterol, alongside Trutakna, a first-of-its-kind therapy for the kidney disease IgA nephropathy.
2h ago